Skip to main content
SpringerLink
Log in

Hotline für maligne Hyperthermie

Neue Telefonnummer für die deutschlandweite „Rund-um-die-Uhr“-Anlaufstelle: 08221/9600

Hotline for malignant hyperthermia

New telephone number for the German nationwide 24 h service center: 08221/9600

  • Medizin aktuell
  • Published:
Der Anaesthesist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literaturauswahl

  1. Adam H, Gottschaldt U, Pausch NC et al (2007) Fulminante Maligne Hyperthermie – Untypischer Verlauf während der 9. Allgemeinanästhesie. Anasthesiol Intensivmed Notfallmed Schmerzther 42:692–699

    Article  PubMed  Google Scholar 

  2. Brandt A, Schleithoff L, Jurkat-Rott K et al (1999) Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with the in-vitro contracture test. Hum Mol Genet 8:2055–2062

    Article  CAS  PubMed  Google Scholar 

  3. Carpenter D, Robinson RL, Quinnell RJ et al (2009) Genetic variation in RYR1and malignant hyperthermia phenotypes. Br J Anaesth 103:538–548

    Article  CAS  PubMed  Google Scholar 

  4. Denborough MA, Forster JF, Lovell RR et al (1962) Anaesthetic deaths in a family. Br J Anaesth 34:395–396

    Article  CAS  PubMed  Google Scholar 

  5. Girard T, Treves S, Voronkov E et al (2004) Molecular genetic testing for malignant hyperthermia susceptibility. Anesthesiology 100:1076–1080

    Article  PubMed  Google Scholar 

  6. Green-Larach M, Russel-Localio A, Allen G et al (1994) A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology 80:771–779

    Article  Google Scholar 

  7. Hopkins PM (2000) Malignant hyperthermia – advances in clinical management and diagnosis. Br J Anaesth 85:118–128

    Article  CAS  PubMed  Google Scholar 

  8. Jurkat-Rott K, McCarthy TV, Lehmann-Horn F (2001) Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve 23:4–17

    Article  Google Scholar 

  9. Klingler W, Lehmann-Horn F, Jurkat-Rott K (2005) Complications of anaesthesia in neuromuscular disorders. Neuromuscul Disord 15:195–206

    Article  PubMed  Google Scholar 

  10. Klingler W, Rueffert H, Lehmann-Horn F et al (2009) Core myopathies and risk of malignant hyperthermia. Anesth Analg 109:1167–1173

    Article  PubMed  Google Scholar 

  11. Levano S, Vukcevic M, Singer M et al (2009) Increasing the number of diagnostic mutations in malignant hyperthermia. Hum Mutat 30:590–598

    Article  CAS  PubMed  Google Scholar 

  12. MacLennan DH, Phillips MS (1992) Malignant hyperthermia. Science 256:789–794

    Article  CAS  PubMed  Google Scholar 

  13. McCarthy TV, Healy J, Lehane M et al (1990) Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q11.2–13.2. Nature 343:562–563

    Article  CAS  PubMed  Google Scholar 

  14. Melzer W, Dietze B (2001) Malignant hyperthermia and excitation-contraction coupling. Acta Physiol Scand 171:367–378

    Article  CAS  PubMed  Google Scholar 

  15. Monnier N, Romero NB, Lerale J et al (2001) Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor. Hum Mol Genet 10:2581–2592

    Article  CAS  PubMed  Google Scholar 

  16. Ording H, Glahn K, Gardi T et al (1997) In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. Acta Anaesth Scand 41:955–963, Appendix: The European Group protocol for investigation of malignant hyperthermia susceptibility. Acta Anaesth Scand 41:964–966

    Google Scholar 

  17. Robinson RL, Anetseder M, Brancadoro V et al (2003) Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing? Eur J Hum Genet 11:342–348

    Article  CAS  PubMed  Google Scholar 

  18. Rosenberg H, Davis M, James D et al (2007) Malignant hyperthermia. Orphanet J Rare Dis 24:2–21

    Google Scholar 

  19. Rueffert H, Olthoff D, Deutrich C et al (2002) Mutation screening in the ryanodine receptor 1 gene (RyR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations. Acta Anaesthesiol Scand 46:692–698

    Article  CAS  PubMed  Google Scholar 

  20. Schuster F, Müller-Reible CR (2009) Maligne Hyperthermie – Diagnostik, Therapie und Narkoseführung. Anasthesiol Intensivmed Notfallmed Schmerzther 44:758–763

    Article  PubMed  Google Scholar 

  21. Treves S, Jungbluth H, Muntoni F, Zorzato F (2008) Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm. Curr Opin Pharmacol 8:319–326

    Article  CAS  PubMed  Google Scholar 

  22. Urwyler A, Deufel T, McCarthy T, West S (2001) Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia. Br J Anaesth 86:283–287

    Article  CAS  PubMed  Google Scholar 

  23. Wappler F (2001) Malignant hyperthermia. Eur J Anaesthesiol 18:632–652

    CAS  PubMed  Google Scholar 

Download references

Danksagung

Prof. Dr. Dr. h.c. Frank Lehmann-Horn ist Seniorforschungsprofessor der gemeinnützigen Hertie-Stiftung.

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehung hin: Die Hotline wird von der Fa. Spepharm, München (http://www.dantrolen.de), gefördert.

Author information

Authors and Affiliations

  1. Neuroanästhesie, Neurochirurgische Universitätsklinik Ulm, BKH Günzburg, Ludwig Heilmeyer Str. 2, 89312, Günzburg, Deutschland

    W. Klingler

  2. Universitätsklinik für Anästhesiologie, Universität Ulm, Ulm, Deutschland

    W. Klingler

  3. Abteilung für Neurophysiologie, Universität Ulm, Ulm, Deutschland

    W. Klingler & F. Lehmann-Horn

  4. Klinik für Anästhesie und Operative Intensivmedizin, SLK-Kliniken Heilbronn GmbH, Heilbronn, Deutschland

    U. Schulte-Sasse

Authors
  1. W. Klingler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Lehmann-Horn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. Schulte-Sasse
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. Klingler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klingler, W., Lehmann-Horn, F. & Schulte-Sasse, U. Hotline für maligne Hyperthermie. Anaesthesist 60, 172–174 (2011). https://doi.org/10.1007/s00101-011-1851-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-011-1851-x

Search

Navigation